Every year, between 250,000 and 300,000 people in Germany suffer from a stroke or heart attack. These patients suffer immune ...
X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in ...
[96] Early diagnosis and appropriate immunoglobulin (Ig) replacement therapy are fundamental for the favorable clinical outcome of common variable immunodeficiency (CVID) patients. Patients with ...
In certain cases, identical mutations can cause severe or partial T-cell immunodeficiency, highlighting the complexity of pathogenesis. For both severe and partial T-cell immunodeficiencies in ...
FIV is spread through contact with infected saliva, and can cause symptoms such as fever, weight loss, and eye and mouth ...
FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare ...
PIDs represent a group of inherited conditions that compromise the body's immune system, leaving individuals susceptible to ...
Sequence variations in human immunodeficiency virus (HIV)-1 reverse transcriptase (RT) and protease, the molecular targets of anti-retroviral drug therapy, are prime examples of genes in which ...
A team of researchers led by Dr. Hirotsugu Oda at the University of Cologne's CECAD Cluster of Excellence for Aging Research ...
The study 'Biallelic human SHARPIN loss of function produces autoinflammation and immunodeficiency' was published in the ...
April 29 (Reuters) - X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in patients 12 years of age and older, sending its ...